Probst Pascal, Hüttner Felix J, Meydan Ömer, Kalkum Eva, Kretschmer Rüdiger, Jensen Katrin, Kenngott Hannes G, Mihaljevic André L, Hackert Thilo, Büchler Markus W, Diener Markus K
Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany
The Study Center of the German Surgical Society (SDGC), University of Heidelberg, Heidelberg, Germany.
BMJ Open. 2019 Sep 30;9(9):e032353. doi: 10.1136/bmjopen-2019-032353.
Pancreatic surgery is a large and complex field of research. Several evidence gaps exist for specific diseases or surgical procedures. An overview on existing knowledge is needed to plan and prioritise future research. The aim of this project is to create a systematic and living evidence map of pancreatic surgery.
A systematic literature search in MEDLINE (via PubMed), Web of Science and Cochrane Central Register of Controlled Trials will be performed searching for all randomised controlled trials (RCT) and systematic reviews (SR) on pancreatic surgery. RCT and SR will be grouped in research topics. Baseline and outcome data from RCT will be extracted, presented and effect sizes meta-analysed. Data from SR will be used to identify evidence gaps. A freely accessible web-based evidence map in the format of a mind map will be created. The evidence map and meta-analyses will be updated periodically.
After completion of the project, a permanently updated evidence map of pancreatic surgery will be available to patients, physicians, researchers and funding bodies via www.evidencemap.surgery. Its use will allow clinical decision-making based on primary data and prioritisation of future research endeavours.
CRD42019133444.
胰腺手术是一个庞大且复杂的研究领域。对于特定疾病或手术操作存在一些证据空白。需要对现有知识进行概述,以便规划未来研究并确定其优先级。本项目的目的是创建一个关于胰腺手术的系统且动态更新的证据图谱。
将在MEDLINE(通过PubMed)、科学网和Cochrane对照试验中心注册库中进行系统文献检索,以查找所有关于胰腺手术的随机对照试验(RCT)和系统评价(SR)。RCT和SR将按研究主题分组。将提取、呈现RCT的基线和结局数据,并对效应量进行荟萃分析。SR的数据将用于识别证据空白。将创建一个以思维导图形式呈现的可免费访问的基于网络的证据图谱。证据图谱和荟萃分析将定期更新。
项目完成后,胰腺手术的永久更新证据图谱将通过www.evidencemap.surgery供患者、医生、研究人员和资助机构使用。其使用将使基于原始数据的临床决策以及未来研究工作的优先级确定成为可能。
PROSPERO注册号:CRD42019133444。